Interleukin 6 and apolipoprotein e as predictors of acute brain dysfunction and survival in critical care patients

American Journal of Critical Care

Volumn 23, Issue 1, 2014, Pages 49-57

  Alexander, Sheila A ^a   Ren, Dianxu ^a   Gunn, Scott R ^a   Kochanek, Patrick M ^b   Tate, Judith ^b   Ikonomovic, Milos ^b   Conley, Yvette P ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; BIOLOGICAL MARKER; DNA; INTERLEUKIN 6;

ACUTE DISEASE; ADULT; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD; BRAIN DISEASE; COGNITIVE DEFECT; COMA; DELIRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; GENOTYPE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; STATISTICS; UNITED STATES;

ACUTE DISEASE; ADULT; APACHE; APOLIPOPROTEIN E4; BIOLOGICAL MARKERS; BRAIN DISEASES; COGNITION DISORDERS; COMA; DELIRIUM; DNA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMANS; INTENSIVE CARE UNITS; INTERLEUKIN-6; LENGTH OF STAY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PENNSYLVANIA; PROGNOSIS; RESPIRATION, ARTIFICIAL;

EID: 84891786807     PISSN: 10623264     EISSN: None     Source Type: Journal    
DOI: 10.4037/ajcc2014578     Document Type: Article

References (37)

1. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik T. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66-73.
2. van Eijk MMJ. Slooter AJC. Delirium in intensive care unit patients. Semin Cardiothorac Vasc Anesth. 2010;14(2):141- 147.
3. Pisani MA, Arauio KL, Van Ness PH, Zhang Y, Ely EW, Innoye SK. A research algorithm to improve detection of delirium in the intensive care unit. Crit Care. 2006;10(4):R121.
4. Witlox J, Eurelings LSM, de Jonghe JFM, Kalisvaart KJ, Eikelenboom P, van Gool WA. Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis. JAMA. 2010;304(4):443-451.
5. Girard TD, Pandharipande PP, Carson SS, et al; MIND Trial Investigators. Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial. Crit Care Med. 2010;38(2):428-437.
6. Morandi A, Brummel NE, Ely EW. Sedation, delirium and mechanical ventilation: the "ACDE" approach. Curr Opin Crit Care. 2011;17(1):43-49.
7. Young J, Inouye SK. Delirium in older people. BMJ. 2007; 334(7598):842-846.
8. Comim CM, Viela MC, Constantino CS, et al. Traffic of leukocytes and cytokine up-regulation in the central nervous system in sepsis. Intensive Care Med. 2011;37(4):711-718.
9. Adamis D, Treloar A, Martin FC, Gregson N, Hamilton G, Macdonald AJ. APOE and cytokines as biological markers for recovery of prevalent delirium in elderly medical inpatients. Int J Geriatr Psychiatry. 2007;22(7):688-694.
10. Vergehese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011;10(3):241-252.
11. Ely EW, Girard TD, Shintani AK, et al. Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients. Crit Care Med. 2007;35(1):112-1127.
12. Leung JM, Sands LP, Wang Y, et al. Apolipoprotein E e4 allele increases the risk of early postoperative delirium in older patients undergoing noncardiac surgery. Anesthesiology. 2007;107(3):406-411.
13. van Munster BC, Korevaar JC, Zwinderman AH, Leeflang MM, de Rooij SE. The association between delirium and the apolipoprotein E epsilon 4 allele: new study results and a meta-analysis. Am J Geriatr Psychiatry. 2009;17(10):856-862.
14. Tagarakis GI, Tsolaki-Tagaraki F, Tsolaki M, Diegeler A, Tsilimingas NB, Papassotiropoulos A. The role of apolipoprotein E in cognitive decline and delirium after bypass heart operations. Am J Alzheimers Dis Other Demen. 2007;22(3):223-228.
15. van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH. The association between delirium and the apolipoprotein E epsilon 4 allele in the elderly. Psychiatr Genet. 2007;17(5):261-266.
16. Bryson GL, Wyand A, Wozny D, Rees L, Tailaard M, Nathan H. A prospective cohort study evaluating associations among delirium, postoperative cognitive dysfunction, and apolipoprotein E genotype following open aortic repair. Can J Anaesth. 2011;58(3):246-255.
17. Silbert S, Evered LA, Scott DA, Cowie TF. The apolipoprotein E e4 allele is not associated with cognitive dysfunction in cardiac surgery. Ann Thorac Surg. 2008;86(3):841-847.
18. Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30(9):1350-1360.
19. 112 inhibits NF- Bκ signaling, proinflammatory cytokine expression, and disease activity in murine models of colitis. J Biol Chem. 2011;286(5):3839-3850.
20. Laskowitz DT, Song P, Wang H, et al. Traumatic brain injury exacerbates neurodegenerative pathology: improvement with an apolipoprotein E-based therapeutic. J Neurotrauma. 2010;27(11):1983-1995.
21. Lynch JR, Wang H, Mace B, et al. A novel therapeutic derived from apolipoprotein E reduces brain inflammation and improves outcome after closed head injury. Exp Neurol. 2005;192(1):109-116.
22. Tsoi LM, Wong KY, Liu YM, Ho YY. Apoprotein E isoformdependent expression and secretion of pro-inflammatory cytokines TNF-a and IL-6 in macrophages. Arch Biochem Biophys. 2007;460(1):33-40.
23. Maezawa I, Nivison M, Montine KS, Maeda N, Montine TJ. Neurotoxicity from innate immune response is greatest with targeted replacement of E4 allele of apolipoprotein E gene and is mediated by microglial p38MAPK. FASEB J. 2006;20(6):797-799.
24. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987; 40(5):373-383.
25. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest. 1991;100(6):1619-1636.
26. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10) 1338-1344.
27. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001;286(21):2703-2710.
28. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
29. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990;31(3):545-548.
30. Rudolph JL, Ramlawi B, Kuchel GA, et al. Chemokines are associated with delirium after cardiac surgery. J Gerontol A Biol Sci Med Sci. 2008;63(2):184-189.
31. Wang M, Jia J. The interleukin-6 gene -572C/G promoter polymorphism modifies Alzheimer's risk in APOEe4 carriers. Neurosci Lett. 2010;482(3):260-263.
32. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging. 2007;28(11):1637-1643.
33. Desai SV, Law TJ, Needham DM. Long-term complications of critical care. Crit Care Med. 2011;39(2):371-379.
34. Poirier J. Apolipoprotein E and cholesterol metabolism in the pathogenesis and treatment of Alzheimer's disease. Trends Mol Med. 2003;9(3):94-101.
35. Oria RB, Patrick PD, Zhang H, et al. APOE4 protects the cognitive development in children with heavy diarrhea burdens in Northeast Brazil. Pediatr Res. 2005;57(2):310-316.
36. Wright RO, Hu H, Silverman EK, et al. Apolipoprotein E genotype predicts 24-month Bayley Scales infant development score. Pediatr Res. 2003;54(6):81+9-25.
37. Li L, Thompson PA, Kitchens RL. Infection induces a positive acute phase apolipoprotein E response from a negative acute phase gene: role of hepatic LDL receptors. J Lipid Res. 2008;49(8):1782-1793.